Trial intelligence / Profile preview

Albumin in Septic Cirrhotic Patients with Non-SBP Infections

NCT01359813Phase 3Terminated

Sponsor
CHU de Besançon
Start
Dec 2008
Primary completion
Sep 2011
Modality
Recombinant Proteins and Enzymes, Tissue Cells
Countries
1
01

Overview

A Phase 3 trial of human albumin in sepsis, Cirrhosis, sponsored by CHU de Besançon. Started Dec 2008; status: terminated.

02

Drugs

human albumin
03

Conditions

sepsisCirrhosis

Beyond the preview

Go deeper on NCT01359813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01359813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call